Oppenheimer Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Oppenheimer Asset Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,326	Closed	-$354K	–	1191
2024 Q1	$354K	Sell	19,326 -4,960	-20%	-$78.7K	0.01%	926
2023 Q4	$298K	Sell	24,286 -1,068	-4%	-$10K	﹤0.01%	996
2023 Q3	$380K	Buy	25,354 +7,781	+44%	+$162K	0.01%	917
2023 Q2	$571K	Buy	+17,573	New	+$642K	0.01%	834
2021 Q2	–	Sell	-4,803	Closed	-$243K	–	1232
2021 Q1	$243K	Buy	4,803 +104	+2%	+$5.78K	﹤0.01%	1069
2020 Q4	$296K	Buy	4,699 +215	+5%	+$13.3K	﹤0.01%	991
2020 Q3	$301K	Sell	4,484 -6,918	-61%	-$378K	0.01%	935
2020 Q2	$478K	Buy	+11,402	New	+$438K	0.01%	807

Other funds holding SILK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Oppenheimer Asset Management's SILK Position: Q2 2024 in Review

Oppenheimer Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 19,326 shares — an estimated $354K sold.

Oppenheimer Asset Management first reported a position in SILK in Q2 2020 and held it in 8 quarters. The position peaked at $571K in Q2 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

Oppenheimer Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Oppenheimer Asset Management sold 19,326 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $354K.
Oppenheimer Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Oppenheimer Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $571K in Q2 2023.
172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Oppenheimer Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.